Yongsheng Lu Quan Shi Jing Yu
10.1177/2058738420934611
Int J Immunopathol Pharmacol
2020 Jan-Dec;34:2058738420934611.
penicilliosis marneffei histoplasmosis immunosuppression methamphetamine talaromycosis
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/32674642/
Amphetamine-Related Disorders / complications Central Nervous System Stimulants / adverse effects Immunocompromised Host Methamphetamine / adverse effects Mycoses / microbiology Opportunistic Infections / microbiology
Amphetamine-Related Disorders / complications Central Nervous System Stimulants / adverse effects Immunocompromised Host Methamphetamine / adverse effects Mycoses / microbiology Opportunistic Infections / microbiology Case Reports Letter Amphetamine-Related Disorders / diagnosis Amphetamine-Related Disorders / immunology Antifungal Agents / therapeutic use Humans Itraconazole / therapeutic use Male Mycoses / diagnosis Mycoses / drug therapy Mycoses / immunology Opportunistic Infections / diagnosis Opportunistic Infections / drug therapy Opportunistic Infections / immunology Treatment Outcome Young Adult Antifungal Agents Central Nervous System Stimulants Itraconazole Methamphetamine talaromycosis
PMC7370326
32674642
Drug-related talaromycosis: A case report
2020